As of May 27
| 0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 31.07, with a high estimate of 53.77 and a low estimate of 11.35. The median estimate represents a +101.90% increase from the last price of 15.39.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.